Kewaunee Scientific Corp Files 8-K on Financials
Ticker: KEQU · Form: 8-K · Filed: Mar 6, 2024 · CIK: 55529
| Field | Detail |
|---|---|
| Company | Kewaunee Scientific CORP /De/ (KEQU) |
| Form Type | 8-K |
| Filed Date | Mar 6, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $2.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k
Related Tickers: KEQU
TL;DR
KEQU filed an 8-K on March 6th detailing financial results. Check it out.
AI Summary
Kewaunee Scientific Corporation filed an 8-K on March 6, 2024, to report on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. Kewaunee Scientific Corporation, incorporated in Delaware, is headquartered in Statesville, NC.
Why It Matters
This filing provides investors with crucial updates on Kewaunee Scientific Corporation's financial performance and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting financial results and does not indicate any unusual or significant risks.
Key Players & Entities
- Kewaunee Scientific Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Statesville, NC (location) — Principal executive offices
- March 6, 2024 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Kewaunee Scientific Corporation's results of operations and financial condition, including financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on March 6, 2024.
Where is Kewaunee Scientific Corporation's principal executive office located?
Kewaunee Scientific Corporation's principal executive office is located at 2700 West Front Street, Statesville, NC 28677.
In which state was Kewaunee Scientific Corporation incorporated?
Kewaunee Scientific Corporation was incorporated in Delaware.
What is the SIC code for Kewaunee Scientific Corporation?
The Standard Industrial Classification (SIC) code for Kewaunee Scientific Corporation is 3821, which corresponds to Laboratory Apparatus & Furniture.
Filing Stats: 531 words · 2 min read · ~2 pages · Grade level 12.5 · Accepted 2024-03-06 16:34:31
Key Financial Figures
- $2.50 — ange on which registered Common Stock, $2.50 par value KEQU The Nasdaq Global Marke
Filing Documents
- kequ-20240306.htm (8-K) — 29KB
- prfy24q3earningsrelease.htm (EX-99.1) — 168KB
- image_0a.jpg (GRAPHIC) — 7KB
- 0000055529-24-000006.txt ( ) — 341KB
- kequ-20240306.xsd (EX-101.SCH) — 2KB
- kequ-20240306_lab.xml (EX-101.LAB) — 21KB
- kequ-20240306_pre.xml (EX-101.PRE) — 12KB
- kequ-20240306_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition On March 6, 2024, Kewaunee Scientific Corporation issued a press release announcing its financial results for the third quarter of fiscal year 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Kewaunee Scientific Corporation dated March 6, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. KEWAUNEE SCIENTIFIC CORPORATION (Registrant) Date: March 6, 2024 By /s/ Donald T. Gardner III Donald T. Gardner III Vice President, Finance Chief Financial Officer